Stay updated on Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check53 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check68 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on upadacitinib in pediatric patients with severe atopic dermatitis, while a new version number has been added.SummaryDifference13%
- Check75 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 10, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.5%
Stay in the know with updates to Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.